Excluding some socially essential workers aged 18 to 49 and those who have received residual vaccines, about 17.77 million people will be vaccinated against the new coronavirus infection (COVID-19) between August and September. Excluding 2 million people who are vaccinated through local government autonomous vaccination, it is expected that 15.77 million people will participate in this 10-part system reservation. The government maintains that the supply of vaccines to be additionally introduced into Korea by September is sufficient for a total of 71 million doses.
According to the Corona 19 Vaccination Response Promotion Team on the 30th, the pre-booking time for 18-49 year olds is from 8:00 pm every day to 6:00 pm the next day. From the 9th to the 18th of the next month, reservations for 10 sub-systems will be accepted, and from the 19th to the 21st, additional reservations will be made for those who have not made a reservation. On the 19th, 36-49 years old, on the 20th, 18-35 years old, and on the 21st, 18-49 years old can make additional reservations. Also, from the 22nd of next month to the 17th of September, all participants, including those who did not participate in the 10-part reservation system, can make additional reservations or change existing reservations.
The vaccination period for 18-49 year-olds is from August 26 to September 30. All primary vaccinations are carried out with mRNA vaccines. In August, 28 million doses of direct contracts for AstraZeneca, Pfizer, and Moderna vaccines and 835,000 doses of AstraZeneca vaccine through ‘Covax Facility’ will arrive. About 2 million doses of the Moderna vaccine, which was scheduled to be introduced this month, will also be supplied next week. In September, a total of 42 million servings will be supplied.
However, it is expected that those in their 40s and younger who will receive the mRNA vaccine between August and September will know which vaccine, Pfizer or Moderna, will be given after the weekly vaccine supply schedule is finalized. Jeong Eun-kyung, head of the promotion group, said, “The specific supply schedule for each type of vaccine is different, so once the weekly supply schedule is confirmed, the type of vaccine will be announced.”
8 million people aged 60 to 74 who completed the first vaccination in the first half of the year will receive the second dose from next month with the AstraZeneca vaccine. The Janssen vaccine was introduced in 100,000 doses out of individual contracts the day before. This amount is planned to be used for seafarers who have difficulty staying in Korea for a long time, homeless people who have difficulty managing two doses of vaccination, and undocumented foreigners.
Meanwhile, the Novavax vaccine, which is scheduled to receive 20 million doses in the second half of the year, has not received domestic approval. The Ministry of Food and Drug Safety has been conducting a preliminary review for three months after receiving an application from SK Bioscience, which is in charge of domestic production and approval of the Novavax vaccine.
The industry is concerned about Novavax’s small size and lack of experience in the drug approval review process. This is because it is too burdensome for the Ministry of Food and Drug Safety to approve a vaccine that has not been approved for use in the United States and Europe for the first time in the world.
[ⓒ 세계일보 & Segye.com, 무단전재 및 재배포 금지]
Source: 세계일보 by www.segye.com.
*The article has been translated based on the content of 세계일보 by www.segye.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!